JP2015143256A5 - - Google Patents

Download PDF

Info

Publication number
JP2015143256A5
JP2015143256A5 JP2015071166A JP2015071166A JP2015143256A5 JP 2015143256 A5 JP2015143256 A5 JP 2015143256A5 JP 2015071166 A JP2015071166 A JP 2015071166A JP 2015071166 A JP2015071166 A JP 2015071166A JP 2015143256 A5 JP2015143256 A5 JP 2015143256A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
range
layer
ethyl acrylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015071166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015143256A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015143256A publication Critical patent/JP2015143256A/ja
Publication of JP2015143256A5 publication Critical patent/JP2015143256A5/ja
Pending legal-status Critical Current

Links

JP2015071166A 2008-11-18 2015-03-31 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤 Pending JP2015143256A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08105817.4 2008-11-18
EP08105817 2008-11-18
EP09100311.1 2009-06-02
EP09100311 2009-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011543762A Division JP5954889B2 (ja) 2008-11-18 2009-11-17 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤

Publications (2)

Publication Number Publication Date
JP2015143256A JP2015143256A (ja) 2015-08-06
JP2015143256A5 true JP2015143256A5 (enExample) 2016-02-12

Family

ID=41395028

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011543762A Active JP5954889B2 (ja) 2008-11-18 2009-11-17 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤
JP2015071166A Pending JP2015143256A (ja) 2008-11-18 2015-03-31 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011543762A Active JP5954889B2 (ja) 2008-11-18 2009-11-17 2−オキソ−1−ピロリジン誘導体を含む持続放出製剤

Country Status (18)

Country Link
US (1) US8460712B2 (enExample)
EP (1) EP2358361B1 (enExample)
JP (2) JP5954889B2 (enExample)
KR (2) KR101788804B1 (enExample)
CN (2) CN104083341A (enExample)
AU (1) AU2009317279B2 (enExample)
BR (1) BRPI0921301A2 (enExample)
CA (1) CA2741038C (enExample)
DK (1) DK2358361T3 (enExample)
EA (1) EA019583B1 (enExample)
ES (1) ES2602606T3 (enExample)
HK (1) HK1198288A1 (enExample)
HU (1) HUE030963T2 (enExample)
IL (1) IL212271A (enExample)
MX (1) MX356281B (enExample)
PL (1) PL2358361T3 (enExample)
PT (1) PT2358361T (enExample)
WO (1) WO2010057869A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2358360T3 (en) * 2008-11-18 2016-12-12 Ucb Biopharma Sprl EXTENDED release formulations comprising one 2-OXO-1 PYRROLIDIN DERIVATIVE
EP3397253A1 (en) 2015-12-30 2018-11-07 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
WO2017195144A1 (en) * 2016-05-12 2017-11-16 Jubilant Generics Limited Pharmaceutical compositions comprising brivaracetam
CA3216586A1 (en) * 2021-05-11 2022-11-17 Caroline Roussel-Maupetit Prolonged-release pharmaceutical composition for oral administration of sultiame
CN115721624A (zh) * 2021-08-25 2023-03-03 北京海美源医药科技有限公司 一种布立西坦药物组合物及其制备方法和其应用
TR2023017170A1 (tr) * 2023-12-13 2025-06-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bri̇varasetam i̇çeren bi̇r saşe formülasyonu

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
NZ556630A (en) * 2005-01-27 2010-12-24 Alembic Ltd Extended release formulation of levetiracetam including a hydrophilic rate controlling polymer
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
WO2006088864A1 (en) * 2005-02-16 2006-08-24 Elan Pharma International Limited Controlled release compositions comprising levetiracetam
US8431156B2 (en) * 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition
JP2008534530A (ja) * 2005-03-29 2008-08-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 活性成分放出に関して調節作用を有する物質を有するペレットを含有している多粒子薬剤形
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
BRPI0712325A2 (pt) * 2006-06-08 2012-01-10 Ucb Pharma Sa processo para a preparação de co-cristais de pirrolidinonas, co-cristal, composição farmacêutica, e, uso de um co-cristal
ES2953390T3 (es) 2006-08-31 2023-11-10 Adare Pharmaceuticals Inc Sistemas de administración de fármacos que comprenden disoluciones sólidas de fármacos débilmente básicos
WO2008062446A2 (en) * 2006-09-14 2008-05-29 Alembic Limited An extended release composition of levetiracetam, which exhibits no adverse food effect
US9555006B2 (en) * 2007-09-21 2017-01-31 Evonik Roehm Gmbh PH-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
BRPI0908421C1 (pt) 2008-03-03 2021-05-25 Ucb Biopharma Sprl solução estável de um composto farmacêutico

Similar Documents

Publication Publication Date Title
JP2015120756A5 (enExample)
JP2015143256A5 (enExample)
HRP20171506T1 (hr) Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
HRP20191092T1 (hr) Pripravci za oralno doziranje s odgođenim otpuštanjem koji sadrže amorfni cddo-me
KR102229234B1 (ko) 폴리비닐알코올 필름
HRP20171458T1 (hr) Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
AR017747A1 (es) Perlas farmaceuticas con recubrimiento entcrico, opcionalmente recubiertas con un anti-adherente dispuesto en el exterior de dicho recubrimiento entcrico, y un procedimiento para preparar dichas perlas farmaccuticas con recubrimiento entcrico
RU2015110824A (ru) Фармацевтическая или нутрицевтическая композиция с замедленным высвобождением и стойкостью к воздействию этанола
JP2012515163A5 (enExample)
JP2004518750A (ja) 貯蔵安定性を改良するための、医薬品配合物用被覆材料および結合材料
JP2009502487A5 (enExample)
JP2005514386A5 (enExample)
SK106295A3 (en) Thermoplastic for drug covers production, manufacturing process and use thereof
SK280487B6 (sk) Poťahovacie a spojivové látky na liekové formy, ic
JP2010519228A (ja) 作用物質−マトリックス及びポリマー被覆を有しているペレット並びにこのペレットを製造する方法
HRP20150123T1 (hr) Plutajući farmaceutski oblici kontroliranog oslobađanja
JP2006274272A5 (enExample)
JP2020007550A5 (enExample)
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
JP2016535030A5 (enExample)
JP2017532363A5 (enExample)
JP2020516741A5 (enExample)
JP2019513800A5 (enExample)
JP2013537896A (ja) 酸性有効成分のための保護コーティング
JP2013502993A5 (enExample)